{"cluster": 62, "subcluster": 9, "abstract_summ": "To join worldwide efforts in identifying potential drug targets against this pandemic, the target landscape of NHC was defined by extracting all known targets of its chemical neighborhood, including drugs, analogues, and metabolites, and by performing target predictions from two independent platforms, following the recent Public Health Assessment via Structural Evaluation (PHASE) protocol.Here we suggest including nimesulide in the list of drugs to be tested for the identification of co-adjuvants in the treatment of COVID-19.The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (Mpro).Carmofur inhibits viral replication in cells (EC50 = 24.30 \u03bcM) and is a promising lead compound to develop new antiviral treatment for COVID-19.Recent outbreak of novel Coronavirus disease (Covid-19) pandemic around the world is associated with severe acute respiratory syndrome.Carmofur inhibits viral replication in cells (EC50 = 24.30 \u03bcM) and it is a promising lead compound to develop new antiviral treatment for COVID-19.Here after performing docking and molecular dynamics of various small molecules derived as a secondary metabolite from fungi, we propose Flaviolin to act as potent inhibitor of 3-chymotrypsin (3C) like protease (3CLpro) of noval corona virus SARS-CoV2 responsible for pandemic condition caused by coronavirus disease 2019 (COVID-19).ABSTRACT The recent emergence of the novel pathogenic SARS-coronavirus 2 (SARS-CoV-2) is responsible for a worldwide pandemic.The first step of the viral replication cycle [i.e. attachment to the surface of respiratory cells, mediated by the spike (S) viral protein] offers several potential therapeutic targets.", "title_summ": "p-Coumaric acid, Curcumin and their Boronic acid derivatives compared to Hydroxychloroquine and its Boronic acid derivativMolecules inhibit the enzyme activity of 3-chymotrypsin-like cysteine protease of SARS-CoV-2 virus: the experimental and theory studiesThe target landscape of N4-hydroxycytidine based on its chemical neighborhoodStructural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug CarmofurProposing a fungal metabolite-Flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV2 using docking and molecular dynamicsStructural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infectionSARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and MemantineInteraction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic propertiesRepurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19.Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs.Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations.Natural and synthetic potential inhibitors of endoribonuclease Nsp15 encoded by Middle East Respiratory Syndrome Coronavirus (MERS-CoV).", "title_abstract_phrases": "To join worldwide efforts in identifying potential drug targets against this pandemic, the target landscape of NHC was defined by extracting all known targets of its chemical neighborhood, including drugs, analogues, and metabolites, and by performing target predictions from two independent platforms, following the recent Public Health Assessment via Structural Evaluation (PHASE) protocol.Carmofur inhibits viral replication in cells (EC50 = 24.30 \u03bcM) and is a promising lead compound to develop new antiviral treatment for COVID-19.Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs.Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug CarmofurThe antineoplastic drug Carmofur was shown to inhibit SARS-CoV-2 main protease (Mpro).Here we suggest including nimesulide in the list of drugs to be tested for the identification of co-adjuvants in the treatment of COVID-19.Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.In conclusion, as a route to curb viral virulence and abate COVID-19, we point to the E protein of SARS-CoV-2 as an attractive drug target and identify off-label compounds that inhibit it."}